[1] 沈振宙,邵志敏.乳腺肿瘤学[M].上海:上海科学技术出版社,2005:148-154.
[2] 于冀洋,朱光华,史 青,等.肝细胞生长因子与转化生长因子β在肾脏病患儿肾组织中的表达[J].实用儿科临床杂志,2008,23(17):13461348.
[3] 刘 洪,胡宝金,傅 睿,等.原发性肾病综合征患儿肝细胞生长因子及其受体的表达特征[J].实用儿科临床杂志,2009,24(5):345347.
[4] Rubin JS,Chan AM,Bottaro DP,et al.A broadspectrum human lung fibroblastderived mitogen is a variant of hepatocyte growth factor[J].Proc Natl Acad Sci USA,1991,88(2):415-419.
[5] Yamashita J,Ogawa M,Yamashita S,et al.Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer[J].Cancer Res,1994,54(7):1630-1633.
[6] Eichbaum MH,de Rossi TM,Kaul S,et al.Serum levels of hepatocyte growth factor scatter factor in patients with liver metastases from breast cancer[J].Tumour Biol,2007,28(1):36-44.
[7] SheenChen SM,Liu YW,Eng HL,et al.Serum levels of hepatocyte growth factor in patients with breast cancer[J].Cancer Epidemiology Biomarkers & Prevention,2005,14(3):715-717.
[8] Pruefer FG,UngerSaldaa K,Mohamier L,et al.Tumor HGF lacks prognostic significance in mexican breast cancer patients[J].J Exp Clin Cancer Res,2006,25(3):357-364.